Ventrus Biosciences (VTUS) Files 949K Common Shelf for Shareholders
Tweet Send to a Friend
Up)
Ventrus Biosciences (Nasdaq: VTUS) filed a registration with the U.S. Securities and Exchange commission to sell, from time to time, up to 948,378 shares of Common Stock on behalf of Selling Shareholders.
Ventrus will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Ventrus will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Ventrus Biosciences, Inc. and Certain Officers -- VTUS
- Apricus Bio (APRI) Prices 6M Common Stock Offering
- TCP Capital (TCPC) Prices Upsized 4.5M Common Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
